Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis

Genetic or Pharmacologic Blockade of EGFR Inhibits Renal Fibrosis

(2012) N. Liu et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Impaired Angiogenesis in Systemic Sclerosis: The Emerging Role of the Antiangiogenic VEGF165b Splice Variant

(2012) Mirko Manetti et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Targeting Endothelium-Pericyte Cross Talk by Inhibiting VEGF Receptor Signaling Attenuates Kidney Microvascular Rarefaction and Fibrosis

(2011) Shuei-Liong Lin et al.   AMERICAN JOURNAL OF PATHOLOGY

Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle

(2011) H Karvinen et al.   GENE THERAPY

Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis

(2009) Alfiya Akhmetshina et al.   ARTHRITIS AND RHEUMATISM

VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice

(2008) Xue-Mei Ou et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Regulation of scar formation by vascular endothelial growth factor

(2008) Traci A Wilgus et al.   LABORATORY INVESTIGATION

Role of PDGF in fibrotic diseases and systemic sclerosis

(2008) M. Trojanowska   RHEUMATOLOGY

Mechanisms of vascular damage in SSc--implications for vascular treatment strategies

(2008) S. Guiducci et al.   RHEUMATOLOGY

Inhibition of VEGF blocks TGF- 1 production through a PI3K/Akt signalling pathway

(2007) K. S. Lee et al.   EUROPEAN RESPIRATORY JOURNAL